Cargando…

Are the effects of cannabis dependence on glucose metabolism similar to schizophrenia? An FDG PET understanding

BACKGROUND: Cannabis has been associated with transient psychotic states; however, the causal relationship between cannabis and schizophrenia continues to remain a matter of debate. Epidemiological and some biological studies hint at cannabis being an independent risk factor for schizophrenia; this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parkar, Shubhangi R., Ramanathan, Seethalakshmi, Nair, Narendra, Batra, Shefali A., Adarkar, Shilpa A., Kund, Purushottam, Baghel, Nawab Singh, Moghe, S. H.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056181/ https://www.ncbi.nlm.nih.gov/pubmed/21431002 http://dx.doi.org/10.4103/0019-5545.75552

Ejemplares similares

Cannabis dependence: Effects of cannabis consumption on inter-regional cerebral metabolic relationships in an Indian population
por: Parkar, Shubhangi R., et al.
Publicado: (2010)

Regional brain metabolism in schizophrenia: An FDG-PET study
por: Seethalakshmi, R., et al.
Publicado: (2006)

Is this ‘complicated’ opioid withdrawal?
por: Parkar, S.R., et al.
Publicado: (2006)

Drug use pattern for emergency psychiatric conditions in a tertiary care hospital: A prospective observational study
por: Jalgaonkar, Sharmila V., et al.
Publicado: (2021)

Lorazepam-induced Short-term Remission of Symptoms in a Case of Paranoid Schizophrenia
por: Parkar, Shubhangi R., et al.
Publicado: (2011)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

A comparison of the level of functioning in chronic schizophrenia with coping and burden in caregivers
por: Creado, Dean A., et al.
Publicado: (2006)

Polymicrobial Pyomyositis in a Patient with Suspected Myeloma on (18)F-FDG PET-CT
por: Kalra, Simran, et al.
Publicado: (2022)

Residual Negative Symptoms Differentiate Cognitive Performance in Clinically Stable Patients with Schizophrenia and Bipolar Disorder
por: Krishnadas, Rajeev, et al.
Publicado: (2014)

A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue
por: Tripathi, Raakhi, et al.
Publicado: (2021)

Detection of Diffuse Infiltrative Primary Hepatic Lymphoma on FDG PET-CT: Hallmarks of Hepatic Superscan
por: Mahajan, Sonia, et al.
Publicado: (2016)

Elderly Mental Health: Needs*
por: Parkar, Shubhangi R.
Publicado: (2015)

Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India
por: Tripathi, Raakhi K, et al.
Publicado: (2022)

Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
por: Townsend, Leigh, et al.
Publicado: (2023)

Detection of Metastatic Disease in Cardiophrenic Lymph Nodes: FDG PET/CT Versus Contrast-Enhanced CT and Implications for Staging and Treatment of Disease
por: Farmakis, Shannon, et al.
Publicado: (2013)

Examining the evolving utility of (18)FDG-PET/CT in breast cancer recurrence
por: Djassemi, Navid, et al.
Publicado: (2020)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

A Cross-sectional comparative study of health concerns associated with screen addiction
por: kaur, Manmeet, et al.
Publicado: (2022)

Cannabis Use and Cognition in Schizophrenia
por: Løberg, Else-Marie, et al.
Publicado: (2009)

Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia
por: van Amsterdam, Jan, et al.
Publicado: (2018)

A comparative study of coping skills and body image: Mastectomized vs. lumpectomized patients with breast carcinoma
por: Mahapatro, Fiona, et al.
Publicado: (2005)

Neuropsychiatric manifestations of methyl iodide
por: Parkar, Shubhangi R., et al.
Publicado: (2012)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

FDG-PET and colon cancer
por: Miles, Ken
Publicado: (2015)

Soft Neurological Signs and Cognitive Function in Obsessive-compulsive Disorder Patients
por: Dhuri, Chetali Vijay, et al.
Publicado: (2016)

Cannabis use and cognitive impairment in schizophrenia
por: Gonçalves, M., et al.
Publicado: (2022)

Relationship between cannabis use and schizophrenia
por: Vazquez Vazquez, J.J., et al.
Publicado: (2022)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Psychoses of Epilepsy in Pregnancy: A Case Report
por: Fahed, Mario, et al.
Publicado: (2021)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

Effect of SMAW process parameters on similar and dissimilar metal welds: An overview
por: Baghel, Pushp Kumar
Publicado: (2022)

Similar and Differing Distributions Between (18)F-FDG-PET and Arterial Spin Labeling Imaging in Temporal Lobe Epilepsy
por: Sone, Daichi, et al.
Publicado: (2019)

Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia
por: Buadze, Anna, et al.
Publicado: (2010)

Isolated sleep paralysis
por: Sawant, Neena S., et al.
Publicado: (2005)

Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users
por: Johnson, Emma C, et al.
Publicado: (2022)

Riedel’s Thyroiditis with Intense FDG Uptake Demonstrated on FDG PET/CT
por: Mansberg, Robert, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_04ic9c74c7eg9n4jv2d85prb33